Dopaminergic network differences in human impulsivity
- PMID: 20671181
- PMCID: PMC3161413
- DOI: 10.1126/science.1185778
Dopaminergic network differences in human impulsivity
Abstract
Dopamine (DA) has long been implicated in impulsivity, but the precise mechanisms linking human variability in DA signaling to differences in impulsive traits remain largely unknown. By using a dual-scan positron emission tomography approach in healthy human volunteers with amphetamine and the D2/D3 ligand [18F]fallypride, we found that higher levels of trait impulsivity were predicted by diminished midbrain D2/D3 autoreceptor binding and greater amphetamine-induced DA release in the striatum, which was in turn associated with stimulant craving. Path analysis confirmed that the impact of decreased midbrain D2/D3 autoreceptor availability on trait impulsivity is mediated in part through its effect on stimulated striatal DA release.
Figures
Similar articles
-
Dopamine D2/3 Receptor Availabilities and Evoked Dopamine Release in Striatum Differentially Predict Impulsivity and Novelty Preference in Roman High- and Low-Avoidance Rats.Int J Neuropsychopharmacol. 2021 Mar 17;24(3):239-251. doi: 10.1093/ijnp/pyaa084. Int J Neuropsychopharmacol. 2021. PMID: 33151278 Free PMC article.
-
Amphetamine self-administration attenuates dopamine D2 autoreceptor function.Neuropsychopharmacology. 2014 Jul;39(8):1833-42. doi: 10.1038/npp.2014.30. Epub 2014 Feb 11. Neuropsychopharmacology. 2014. PMID: 24513972 Free PMC article.
-
Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement.Science. 2007 Mar 2;315(5816):1267-70. doi: 10.1126/science.1137073. Science. 2007. PMID: 17332411 Free PMC article.
-
Alterations in dopamine release but not dopamine autoreceptor function in dopamine D3 receptor mutant mice.J Neurosci. 1998 Mar 15;18(6):2231-8. doi: 10.1523/JNEUROSCI.18-06-02231.1998. J Neurosci. 1998. PMID: 9482807 Free PMC article. Review.
-
Impulsivity, Stimulant Abuse, and Dopamine Receptor Signaling.Adv Pharmacol. 2016;76:67-84. doi: 10.1016/bs.apha.2016.01.002. Epub 2016 Mar 2. Adv Pharmacol. 2016. PMID: 27288074 Review.
Cited by
-
The dopamine augmenter L-DOPA does not affect positive mood in healthy human volunteers.PLoS One. 2012;7(1):e28370. doi: 10.1371/journal.pone.0028370. Epub 2012 Jan 4. PLoS One. 2012. PMID: 22238577 Free PMC article. Clinical Trial.
-
Pregabalin- and topiramate-mediated regulation of cognitive and motor impulsivity in DBA/2 mice.Br J Pharmacol. 2012 Sep;167(1):183-95. doi: 10.1111/j.1476-5381.2012.01981.x. Br J Pharmacol. 2012. PMID: 22489711 Free PMC article.
-
Increased large-scale inter-network connectivity in relation to impulsivity in Parkinson's disease.Sci Rep. 2020 Jul 10;10(1):11418. doi: 10.1038/s41598-020-68266-x. Sci Rep. 2020. PMID: 32651411 Free PMC article.
-
Future Newborns with Opioid-Induced Neonatal Abstinence Syndrome (NAS) Could Be Assessed with the Genetic Addiction Risk Severity (GARS) Test and Potentially Treated Using Precision Amino-Acid Enkephalinase Inhibition Therapy (KB220) as a Frontline Modality Instead of Potent Opioids.J Pers Med. 2022 Dec 6;12(12):2015. doi: 10.3390/jpm12122015. J Pers Med. 2022. PMID: 36556236 Free PMC article. Review.
-
Amisulpride and l-DOPA modulate subcortical brain nuclei connectivity in resting-state pharmacologic magnetic resonance imaging.Hum Brain Mapp. 2020 May;41(7):1806-1818. doi: 10.1002/hbm.24913. Epub 2019 Dec 27. Hum Brain Mapp. 2020. PMID: 31880365 Free PMC article. Clinical Trial.
References
-
- Malloy-Diniz L, Fuentes D, Leite WB, Correa H, Bechara A. J Int Neuropsychol Soc. 2007 Jul;13:693. - PubMed
-
- Verdejo-Garcia A, Lawrence AJ, Clark L. Neurosci Biobehav Rev. 2008;32:777. - PubMed
-
- Barratt ES, Stanford MS, Dowdy L, Liebman MJ, Kent TA. Psychiatry Res. 1999 May 31;86:163. - PubMed
-
- Cools R, Barker RA, Sahakian BJ, Robbins TW. Neuropsychologia. 2003;41:1431. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources